The widespread adoption of GLP-1 weight-loss medications like Ozempic and Wegovy could put revenue at risk across multiple service lines, according to a March 11 article in Becker’s Hospital Review. As a result, hospitals and…
From operational efficiency and budgetary concerns to staffing issues and vendor relationships, the day-to-day concerns of perioperative professionals are fully reflected in the agenda for the 2025 OR Manager Conference, scheduled for October 28-30 in…
Preoperative use of GLP-1 receptor agonists was not significantly associated with an increased risk of aspiration pneumonia or acute respiratory failure after surgery, according to a March 4 report in MedPage Today. The article focuses…